Yang Wei - Search Results

Year	Number of Results
1998	1
2001	4
2002	19
2003	34
2004	41
2005	65
2006	67
2007	89
2008	121
2009	100
2010	134
2011	140
2012	181
2013	240
2014	241
2015	259
2016	265
2017	344
2018	419
2019	428
2020	461
2021	523
2022	582
2023	586
2024	241

1

IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance.

Han Y, Zhang YY, Pan YQ, Zheng XJ, Liao K, Mo HY, Sheng H, Wu QN, Liu ZX, Zeng ZL, Yang W, Yuan SQ, Huang P, Ju HQ, Xu RH. Han Y, et al. Among authors: yang w. Mol Cell. 2023 Jun 1;83(11):1887-1902.e8. doi: 10.1016/j.molcel.2023.05.011. Epub 2023 May 26. Mol Cell. 2023. PMID: 37244254

2

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.

Huang KK, Ma H, Chong RHH, Uchihara T, Lian BSX, Zhu F, Sheng T, Srivastava S, Tay ST, Sundar R, Tan ALK, Ong X, Lee M, Ho SWT, Lesluyes T, Ashktorab H, Smoot D, Van Loo P, Chua JS, Ramnarayanan K, Lau LHS, Gotoda T, Kim HS, Ang TL, Khor C, Lee JWJ, Tsao SKK, Yang WL, Teh M, Chung H, So JBY, Yeoh KG, Tan P; Singapore Gastric Cancer Consortium. Huang KK, et al. Among authors: yang wl. Cancer Cell. 2023 Dec 11;41(12):2019-2037.e8. doi: 10.1016/j.ccell.2023.10.004. Epub 2023 Oct 26. Cancer Cell. 2023. PMID: 37890493 Free PMC article.

3

Lesion recognition by XPC, TFIIH and XPA in DNA excision repair.

Kim J, Li CL, Chen X, Cui Y, Golebiowski FM, Wang H, Hanaoka F, Sugasawa K, Yang W. Kim J, et al. Among authors: yang w. Nature. 2023 May;617(7959):170-175. doi: 10.1038/s41586-023-05959-z. Epub 2023 Apr 19. Nature. 2023. PMID: 37076618 Free PMC article.

4

Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage.

Liu HW, Gong LN, Lai K, Yu XF, Liu ZQ, Li MX, Yin XL, Liang M, Shi HS, Jiang LH, Yang W, Shi HB, Wang LY, Yin SK. Liu HW, et al. Among authors: yang w. Neuron. 2023 May 17;111(10):1609-1625.e6. doi: 10.1016/j.neuron.2023.02.022. Epub 2023 Mar 14. Neuron. 2023. PMID: 36921602 Free PMC article.

5

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer.

Li JJ, Wang JH, Tian T, Liu J, Zheng YQ, Mo HY, Sheng H, Chen YX, Wu QN, Han Y, Liao K, Pan YQ, Zeng ZL, Liu ZX, Yang W, Xu RH, Ju HQ. Li JJ, et al. Among authors: yang w. Nat Commun. 2023 Oct 23;14(1):6690. doi: 10.1038/s41467-023-42332-0. Nat Commun. 2023. PMID: 37872170 Free PMC article.

6

Single-cell RNA sequencing reveals the fragility of male spermatogenic cells to Zika virus-induced complement activation.

Yang W, Liu LB, Liu FL, Wu YH, Zhen ZD, Fan DY, Sheng ZY, Song ZR, Chang JT, Zheng YT, An J, Wang PG. Yang W, et al. Nat Commun. 2023 Apr 29;14(1):2476. doi: 10.1038/s41467-023-38223-z. Nat Commun. 2023. PMID: 37120617 Free PMC article.

7

Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction.

Ye T, Yang W, Gao T, Yu X, Chen T, Yang Y, Guo J, Li Q, Li H, Yang L. Ye T, et al. Among authors: yang w. Free Radic Biol Med. 2023 Sep;206:143-161. doi: 10.1016/j.freeradbiomed.2023.06.019. Epub 2023 Jun 29. Free Radic Biol Med. 2023. PMID: 37392951 Free article.

8

TRPM2 Mediates Hepatic Ischemia-Reperfusion Injury via Ca²⁺-Induced Mitochondrial Lipid Peroxidation through Increasing ALOX12 Expression.

Zhong C, Yang J, Zhang Y, Fan X, Fan Y, Hua N, Li D, Jin S, Li Y, Chen P, Chen Y, Cai X, Zhang Y, Jiang L, Yang W, Yu P, Lin H. Zhong C, et al. Among authors: yang w. Research (Wash D C). 2023 May 31;6:0159. doi: 10.34133/research.0159. eCollection 2023. Research (Wash D C). 2023. PMID: 37275121 Free PMC article.

9

TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy.

Yu B, Jin L, Yao X, Zhang Y, Zhang G, Wang F, Su X, Fang Q, Xiao L, Yang Y, Jiang LH, Chen J, Yang W, Lin W, Han F. Yu B, et al. Among authors: yang w. Theranostics. 2023 Jul 31;13(13):4356-4375. doi: 10.7150/thno.84655. eCollection 2023. Theranostics. 2023. PMID: 37649595 Free PMC article.

10

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial.

Vos JL, Burman B, Jain S, Fitzgerald CWR, Sherman EJ, Dunn LA, Fetten JV, Michel LS, Kriplani A, Ng KK, Eng J, Tchekmedyian V, Haque S, Katabi N, Kuo F, Han CY, Nadeem Z, Yang W, Makarov V, Srivastava RM, Ostrovnaya I, Prasad M, Zuur CL, Riaz N, Pfister DG, Klebanoff CA, Chan TA, Ho AL, Morris LGT. Vos JL, et al. Among authors: yang w. Nat Med. 2023 Dec;29(12):3077-3089. doi: 10.1038/s41591-023-02518-x. Epub 2023 Aug 24. Nat Med. 2023. PMID: 37620627 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

4,955 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

4,955 results

Results by year